INTERMUNE INC 3 SEC Filings

Filed On	Filing
03 Sep 2013	Form 3: Powell Andrew Kenneth William, EVP, GC & Corp. Secretary Holds 750 shares of Common Stock
20 Feb 2013	Form 3: Nolan Sean P., Executive VP & CBO No securities owned
20 Jul 2012	Form 3: Arata Paul D, Senior VP of HR No securities owned
17 Apr 2012	Form 3: Leff Jonathan A, EVP of R&D Holds 0 shares of No securities are beneficially owned
28 Mar 2012	Form 3: Verwiel Frank, Director Holds 0 shares of No securities are beneficially owned
28 Mar 2012	Form 3: Bienaime Jean Jacques, Director Holds 0 shares of No securities are beneficially owned
02 Nov 2011	Form 3: Russell Angus C., Director No securities owned
09 Dec 2009	Form 3: Cohen Alan Howard, SVP, Medical Affairs No securities owned
09 Nov 2009	Form 3: Di Nepi Giacomo, SVP, Managing Director, Europe No securities owned
20 Mar 2009	Form 3: Seiwert Scott, VP, Rsearch/ Preclinical Dev. Holds 12,700 shares of Common Stock
10 Oct 2007	Form 3: Intermune Inc, 10% owner · Targanta Therapeutics Corp.
07 Sep 2007	Form 3: Drapeau Louis, Director No securities owned
21 Sep 2006	Form 3: Ekman Lars, Director No securities owned
24 Aug 2006	Form 3: Hodgman John, SVP, Finance & CFO No securities owned
02 Dec 2005	Form 3: Kabakoff David S, Director No securities owned
05 Nov 2004	Form 3: Robinson Cynthia Y, SVP of Therapeutic Team No securities owned
25 Oct 2004	Form 3: Halleen Norman, SVP of Finance & No securities owned
18 Oct 2004	Form 3: Kassberg Thomas Richard, Sr. Vice President
18 Oct 2004	Form 3: Bradford Williamson Z Iii, Vice President of Clinical
18 Oct 2004	Form 3: Simon Howard Allan, Sr. Vice President, HR

Comments